Astrocyte reactivity and reactive astrogliosis: Costs and benefits

Physiological Reviews

Volumn 94, Issue 4, 2014, Pages 1077-1098

  Pekny, Milos ^a   Pekna, Marcela ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTE; ASTROCYTE REACTIVITY; ASTROCYTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; CELL ACTIVATION; CELL FUNCTION; CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; DISEASE MODEL; EXPERIMENTAL DISEASE; GENDER; HUMAN; MICROGLIA; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN; CYTOLOGY; PATHOLOGY; PHYSIOLOGY; REGENERATION;

ANIMALS; ASTROCYTES; BRAIN; HUMANS; NEURODEGENERATIVE DISEASES; REGENERATION;

EID: 84921791889     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00041.2013     Document Type: Article

References (278)

1. Abbott NJ. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25: 5–23, 2005.
2. Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24: 565–575, 2004.
3. Abramov AY, Canevari L, Duchen MR. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23: 5088–5095, 2003.
4. Alilain WJ, Horn KP, Hu H, Dick TE, Silver J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 475: 196–200, 2011.
5. Alvarez JI, Katayama T, Prat A. Glial influence on the blood brain barrier. Glia 61: 1939–1958, 2013.
6. Anderson MA, Ao Y, Sofroniew MV. Heterogeneity of reactive astrocytes. Neurosci Lett 565: 23–29, 2014.
7. Andersson D, Wilhelmsson U, Nilsson M, Kubista M, Ståhlberg A, Pekna M, Pekny M. Plasticity response in the contralesional hemisphere after subtle neurotrauma: gene expression profiling after partial deafferentation of the hippocampus. PLoS One 8: e70699, 2013.
8. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, Ferrara N, Sofroniew MV, John GR. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 122: 2454–2468, 2012.
9. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 106: 1977–1982, 2009.
10. Ari C, Kalman M. Glial architecture of the ghost shark (Callorhinchus milii, Holocephali, Chondrichthyes) as revealed by different immunohistochemical markers. J Exp Zool B Mol Dev Evol 310: 504–519, 2008.
11. Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 468: 557–561, 2010.
12. Arnold S, de Araujo GW, Beyer C. Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones. J Mol Endocrinol 41: 289–300, 2008.
13. Aronica E, Ravizza T, Zurolo E, Vezzani A. Astrocyte immune responses in epilepsy. Glia 60: 1258–1268, 2012.
14. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 14: 846–856, 1994.
15. Bardehle S, Kruger M, Buggenthin F, Schwausch J, Ninkovic J, Clevers H, Snippert HJ, Theis FJ, Meyer-Luehmann M, Bechmann I, Dimou L, Gotz M. Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci 16: 580–586, 2013.
16. Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60: 430–440, 2008.
17. Baumgart EV, Barbosa JS, Bally-Cuif L, Gotz M, Ninkovic J. Stab wound injury of the zebrafish telencephalon: A model for comparative analysis of reactive gliosis. Glia 60: 343–357, 2012.
18. Beach TG, Walker R, McGeer EG. Patterns of gliosis in Alzheimer’s disease and aging cerebrum. Glia 2: 420–436, 1989.
19. Beck H, Plate KH. Angiogenesis after cerebral ischemia. Acta Neuropathol 117: 481– 496, 2009.
20. Beckervordersandforth R, Tripathi P, Ninkovic J, Bayam E, Lepier A, Stempfhuber B, Kirchhoff F, Hirrlinger J, Haslinger A, Lie DC, Beckers J, Yoder B, Irmler M, Gotz M. In vivo fate mapping and expression analysis reveals molecular hallmarks of prospec-tively isolated adult neural stem cells. Cell Stem Cell 7: 744–758, 2010.
21. Benner EJ, Luciano D, Jo R, Abdi K, Paez-Gonzalez P, Sheng H, Warner DS, Liu C, Eroglu C, Kuo CT. Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4. Nature 497: 369–373, 2013.
22. Berg A, Zelano J, Stephan A, Thams S, Barres BA, Pekny M, Pekna M, Cullheim S. Reduced removal of synaptic terminals from axotomized spinal motoneurons in the absence of complement C3. Exp Neurol 237: 8–17, 2012.
23. Bialas AR, Stevens B. TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat Neurosci 16: 1773–1782, 2013.
24. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389–1392, 2006.
25. Booher J, Sensenbrenner M. Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures. Neurobiology 2: 97–105, 1972.
26. Bradbury EJ, Carter LM. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 84: 306–316, 2011.
27. Bradbury EJ, Moon LDF, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416: 636–640, 2002.
28. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 202: 145–156, 2005.
29. Brambilla R, Hurtado A, Persaud T, Esham K, Pearse DD, Oudega M, Bethea JR. Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem 110: 765–778, 2009.
30. Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27: 117–120, 2001.
31. Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP, Mori T, Gotz M. Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci USA 105: 3581–3586, 2008.
32. Buffo A, Rolando C, Ceruti S. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 79: 77–89, 2010.
33. Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81: 229–248, 2014.
34. Busch SA, Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol 17: 120–127, 2007.
35. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23: 297–308, 1999.
36. Bushong EA, Martone ME, Ellisman MH. Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. Int J Dev Neurosci 22: 73–86, 2004.
37. Bushong EA, Martone ME, Jones YZ, Ellisman MH. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 22: 183– 192, 2002.
38. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264–278, 2008.
39. Carmichael ST. Plasticity of cortical projections after stroke. Neuroscientist 9: 64–75, 2003.
40. Carmignoto G, Haydon PG. Astrocyte calcium signaling and epilepsy. Glia 60: 1227– 1233, 2012.
41. Chen DF, Schneider GE, Martinou JC, Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385: 434–439, 1997.
42. Cho KS, Yang L, Lu B, Feng Ma H, Huang X, Pekny M, Chen DF. Re-establishing the regenerative potential of central nervous system axons in postnatal mice. J Cell Sci 118: 863–872, 2005.
43. Cho W, Brenner M, Peters N, Messing A. Drug screening to identify suppressors of GFAP expression. Hum Mol Genet 19: 3169–3178, 2010.
44. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120: 421–433, 2005.
45. Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C, Joung J, Foo LC, Thompson A, Chen C, Smith SJ, Barres BA. Astrocytes mediate synapse elimina-tion through MEGF10 and MERTK pathways. Nature 504: 394–400, 2013.
46. Clarke SR, Shetty AK, Bradley JL, Turner DA. Reactive astrocytes express the embryonic intermediate neurofilament nestin. Neuroreport 5: 1885–1888, 1994.
47. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468: 305–309, 2010.
48. Colangelo AM, Alberghina L, Papa M. Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci Lett 565: 59–64, 2014.
49. Colucci-Guyon E, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79: 679–694, 1994.
50. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 247: 470–473, 1990.
51. Correa-Cerro LS, Mandell JW. Molecular mechanisms of astrogliosis: new approaches with mouse genetics. J Neuropathol Exp Neurol 66: 169–176, 2007.
52. Cudkowicz ME. Clinical Trial Ceftriaxone in Subjects With ALS. ClinicalTrialsgov #NCT00349622: 2012.
53. Davies SJ, Goucher DR, Doller C, Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 19: 5810–5822, 1999.
54. De Pablo Y, Nilsson M, Pekna M, Pekny M. Intermediate filaments are important for astrocyte response to oxidative stress induced by oxygen-glucose deprivation and reperfusion. Histochem Cell Biol 140: 81–91, 2013.
55. Delaney CL, Brenner M, Messing A. Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. J Neurosci 16: 6908–6918, 1996.
56. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10: 608–614, 2007.
57. Ding M, Eliasson C, Betsholtz C, Hamberger A, Pekny M. Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin. Brain Res 62: 77–81, 1998.
58. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26: 248–254, 2003.
59. Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, Ma G, Bupp S, Shrestha P, Shah RD, Doughty ML, Gong S, Greengard P, Heintz N. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135: 749–762, 2008.
60. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 62: 649– 671, 2000.
61. Duggal N, Schmidt-Kastner R, Hakim AM. Nestin expression in reactive astrocytes following focal cerebral ischemia in rats. Brain Res 768: 1–9, 1997.
62. Eddleston M, Mucke L. Molecular profile of reactive astrocytes–implications for their role in neurologic disease. Neuroscience 54: 15–36, 1993.
63. Eliasson C, Sahlgren C, Berthold CH, Stakeberg J, Celis JE, Betsholtz C, Eriksson JE, Pekny M. Intermediate filament protein partnership in astrocytes. J Biol Chem 274: 23996–24006, 1999.
64. Ellis EF, McKinney JS, Willoughby KA, Liang S, Povlishock JT. A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astro-cytes. J Neurotrauma 12: 325–339, 1995.
65. Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol 4: 229–237, 1994.
66. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem Res 25: 1439–1451, 2000.
67. Eroglu C, Barres BA. Regulation of synaptic connectivity by glia. Nature 468: 223–231, 2010.
68. Erschbamer M, Pernold K, Olson L. Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury. J Neurosci 27: 6428–6435, 2007.
69. Eugenin EA, Basilio D, Saez JC, Orellana JA, Raine CS, Bukauskas F, Bennett MV, Berman JW. The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. J Neuroimmune Pharmacol 7: 499– 518, 2012.
70. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24: 2143–2155, 2004.
71. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 209: 294–301, 2008.
72. Foo LC, Allen NJ, Bushong EA, Ventura PB, Chung WS, Zhou L, Cahoy JD, Daneman R, Zong H, Ellisman MH, Barres BA. Development of a method for the purification and culture of rodent astrocytes. Neuron 71: 799–811, 2011.
73. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI, Fu XY. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabe-tes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 101: 4661–4666, 2004.
74. Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci 7: 1233–1241, 2004.
75. Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W. Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2: e167, 2011.
76. Ge WP, Miyawaki A, Gage FH, Jan YN, Jan LY. Local generation of glia is a major astrocyte source in postnatal cortex. Nature 484: 376–380, 2012.
77. 77a.Geerts A, Pekny M. Hepatic stellate cells and astrocytes: Similarities and differences. In: Hepatic Encephalopathy and Nitrogen Metabolism, edited by Häussinger D. Dor-drecht, the Netherlands: Springer, 2006, p. 87–111.
78. Gleichman AJ, Carmichael ST. Astrocytic therapies for neuronal repair in stroke. Neurosci Lett 565: 47–52, 2014.
79. Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 24: 10064–10073, 2004.
80. Goldshmit Y, Spanevello MD, Tajouri S, Li L, Rogers F, Pearse M, Galea M, Bartlett PF, Boyd AW, Turnley AM. EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice. PloS One 6: e24636, 2011.
81. Gomi H, Yokoyama T, Fujimoto K, Ikeda T, Katoh A, Itoh T, Itohara S. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 14: 29–41, 1995.
82. Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J. A pericyte origin of spinal cord scar tissue. Science 333: 238–242, 2011.
83. Grosche J, Matyash V, Moller T, Verkhratsky A, Reichenbach A, Kettenmann H. Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells. Nat Neurosci 2: 139–143, 1999.
84. Grupp L, Wolburg H, Mack AF. Astroglial structures in the zebrafish brain. J Comp Neurol 518: 4277–4287, 2010.
85. Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, Richardson JA, Hammer RE, Hofmann SL. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci USA 98: 13566–13571, 2001.
86. Haber M, Murai KK. Reshaping neuron-glial communication at hippocampal synapses. Neuron Glia Biol 2: 59–66, 2006.
87. Haberle J, Gorg B, Toutain A, Rutsch F, Benoist JF, Gelot A, Suc AL, Koch HG, Schliess F, Haussinger D. Inborn error of amino acid synthesis: human glutamine synthetase deficiency. J Inherit Metab Dis 29: 352–358, 2006.
88. Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song SW, Likhite S, Murtha MJ, Foust KD, Rao MH, Eagle A, Kammesheidt A, Christensen A, Mendell JR, Burghes AHM, Kaspar BK. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29: 824–879, 2011.
89. Haj-Yasein NN, Vindedal GF, Eilert-Olsen M, Gundersen GA, Skare O, Laake P, Klungland A, Thoren AE, Burkhardt JM, Ottersen OP, Nagelhus EA. Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet. Proc Natl Acad Sci USA 108: 17815–17820, 2011.
90. Han X, Chen M, Wang F, Windrem M, Wang S, Shanz S, Xu Q, Oberheim NA, Bekar L, Betstadt S, Silva AJ, Takano T, Goldman SA, Nedergaard M. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 12: 342–353, 2013.
91. Hauck SM, von Toerne C, Ueffing M. The neuroprotective potential of retinal Muller glial cells. Adv Exp Med Biol 801: 381–387, 2014.
92. He Y, Hakvoort TB, Vermeulen JL, Lamers WH, Van Roon MA. Glutamine synthetase is essential in early mouse embryogenesis. Dev Dyn 236: 1865–1875, 2007.
93. Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, Suarez-Farinas M, Schwarz C, Stephan DA, Surmeier DJ, Greengard P, Heintz N. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135: 738–748, 2008.
94. Hernandez MR, Agapova OA, Yang P, Salvador-Silva M, Ricard CS, Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia 38: 45–64, 2002.
95. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28: 7231–7243, 2008.
96. Hertz L. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacol-ogy 55: 289–309, 2008.
97. Hidalgo A, Urban J, Brand AH. Targeted ablation of glia disrupts axon tract formation in the Drosophila CNS. Development 121: 3703–3712, 1995.
98. Hofmann SL, Das AK, Lu JY, Wisniewski KE, Gupta P. Infantile neuronal ceroid lipofuscinosis: No longer just a “Finnish” disease. Eur J Ped Neurol 5 Suppl A: 47–51, 2001.
99. Hofmann SL, Das AK, Yi W, Lu JY, Wisniewski KE. Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency. Mol Genet Metab 66: 234–239, 1999.
100. Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Intravenous ad-ministration of glial cell line-derived neurotrophic factor gene-modified human mes-enchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84: 1495–1504, 2006.
101. Hostenbach S, Cambron M, D’Haeseleer M, Kooijman R, De Keyser J. Astrocyte loss and astrogliosis in neuroinflammatory disorders. Neurosci Lett 565: 39–41, 2014.
102. Howell GR, Macalinao DG, Sousa GL, Walden M, Soto I, Kneeland SC, Barbay JM, King BL, Marchant JK, Hibbs M, Stevens B, Barres BA, Clark AF, Libby RT, John SW. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest 121: 1429–1444, 2011.
103. Hui SP, Dutta A, Ghosh S. Cellular response after crush injury in adult zebrafish spinal cord. Dev Dyn 239: 2962–2979, 2010.
104. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 10: 1369–1376, 2007.
105. Jaderstad J, Jaderstad LM, Li J, Chintawar S, Salto C, Pandolfo M, Ourednik V, Teng YD, Sidman RL, Arenas E, Snyder EY, Herlenius E. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci USA 107: 5184–5189, 2010.
106. Jarlestedt K, Rousset CI, Faiz M, Wilhelmsson U, Stahlberg A, Sourkova H, Pekna M, Mallard C, Hagberg H, Pekny M. Attenuation of reactive gliosis does not affect infarct volume in neonatal hypoxic-ischemic brain injury in mice. PLoS One 5: e10397, 2010.
107. Jing R, Wilhelmsson U, Goodwill W, Li L, Pan Y, Pekny M, Skalli O. Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks. J Cell Sci 120: 1267–1277, 2007.
108. Kalman M. GFAP expression withdraws–a trend of glial evolution? Brain Res Bull 57: 509–511, 2002.
109. Kamphuis W, Orre M, Kooijman L, Dahmen M, Hol EM. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer’s disease mouse model. Glia 60: 615–629, 2012.
110. Kanemaru K, Kubota J, Sekiya H, Hirose K, Okubo Y, Iino M. Calcium-dependent N-cadherin up-regulation mediates reactive astrogliosis and neuroprotection after brain injury. Proc Natl Acad Sci USA 110: 11612–11617, 2013.
111. Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16: 571–579, 2013.
112. Kerr BJ, Patterson PH. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 188: 391–407, 2004.
113. Kettenmann H, Verkhratsky A. Neuroglia: the 150 years after. Trends Neurosci 31: 653–659, 2008.
114. Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA, Wong M, Sands MS, Cooper JD. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 25: 150–162, 2007.
115. Kimelberg HK, Nedergaard M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7: 338–353, 2010.
116. Kinouchi R, Takeda M, Yang L, Wilhelmsson U, Lundkvist A, Pekny M, Chen DF. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat Neurosci 6: 863–868, 2003.
117. Kitagawa H, Sasaki C, Zhang WR, Sakai K, Shiro Y, Warita H, Mitsumoto Y, Mori T, Abe K. Induction of glial cell line-derived neurotrophic factor receptor proteins in cerebral cortex and striatum after permanent middle cerebral artery occlusion in rats. Brain Res 834: 190–195, 1999.
118. Klein MA, Moller JC, Jones LL, Bluethmann H, Kreutzberg GW, Raivich G. Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19: 227–233, 1997.
119. Kobayashi T, Ahlenius H, Thored P, Kobayashi R, Kokaia Z, Lindvall O. Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 37: 2361–2367, 2006.
120. Koehler RC, Roman RJ, Harder DR. Astrocytes and the regulation of cerebral blood flow. Trends Neurosci 32: 160–169, 2009.
121. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM. Apolipoprotein E promotes astrocyte colocalization and degrada-tion of deposited amyloid-beta peptides. Nat Med 10: 719–726, 2004.
122. Kokaia Z, Airaksinen MS, Nanobashvili A, Larsson E, Kujamaki E, Lindvall O, Saarma M. GDNF family ligands and receptors are differentially regulated after brain insults in the rat. Eur J Neurosci 11: 1202–1216, 1999.
123. Koprivica V, Cho KS, Park JB, Yiu G, Atwal J, Gore B, Kim JA, Lin E, Tessier-Lavigne M, Chen DF, He Z. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310: 106–110, 2005.
124. Kosaka T, Hama K. Three-dimensional structure of astrocytes in the rat dentate gyrus. J Comp Neurol 249: 242–260, 1986.
125. Kraft AW, Hu X, Yoon H, Yan P, Xiao Q, Wang Y, Gil SC, Brown J, Wilhelmsson U, Restivo JL, Cirrito JR, Holtzman DM, Kim J, Pekny M, Lee JM. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J 27: 187–198, 2013.
126. Krakauer JWCS, Corbett D, Wittenberg GF. Getting neurorehabilitation right: what can be learned from animal models? Neurorehab Neural Re 26: 923–931, 2012.
127. Lang B, Liu HL, Liu R, Feng GD, Jiao XY, Ju G. Astrocytes in injured adult rat spinal cord may acquire the potential of neural stem cells. Neuroscience 128: 775–783, 2004.
128. Lange SC, Bak LK, Waagepetersen HS, Schousboe A, Norenberg MD. Primary cultures of astrocytes: their value in understanding astrocytes in health and disease. Neurochem Res 37: 2569–2588, 2012.
129. Laping NJ, Teter B, Nichols NR, Rozovsky I, Finch CE. Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol 4: 259–275, 1994.
130. Lee H, McKeon RJ, Bellamkonda RV. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci USA 107: 3340–3345, 2010.
131. Lepekhin EA, Eliasson C, Berthold CH, Berezin V, Bock E, Pekny M. Intermediate filaments regulate astrocyte motility. J Neurochem 79: 617–625, 2001.
132. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Stahlberg A, Aprico K, Larsson K, Yabe T, Moons L, Fotheringham A, Davies I, Carmeliet P, Schwartz JP, Pekna M, Kubista M, Blomstrand F, Maragakis N, Nilsson M, Pekny M. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 28: 468–481, 2008.
133. Liebner S, Czupalla CJ, Wolburg H. Current concepts of blood-brain barrier development. Int J Dev Biol 55: 467–476, 2011.
134. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17: 607–615, 1996.
135. Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, Hansen TW, Goldman S, Nedergaard M. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1: 494–500, 1998.
136. Lipton SA, Gu Z, Nakamura T. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders. Int Rev Neurobiol 82: 1–27, 2007.
137. Liu Y, Namba T, Liu J, Suzuki R, Shioda S, Seki T. Glial fibrillary acidic protein-expressing neural progenitors give rise to immature neurons via early intermediate progenitors expressing both glial fibrillary acidic protein and neuronal markers in the adult hippocampus. Neuroscience 166: 241–251, 2010.
138. Lovatt D, Sonnewald U, Waagepetersen HS, Schousboe A, He W, Lin JH, Han X, Takano T, Wang S, Sim FJ, Goldman SA, Nedergaard M. The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J Neurosci 27: 12255–12266, 2007.
139. Lu YB, Iandiev I, Hollborn M, Korber N, Ulbricht E, Hirrlinger PG, Pannicke T, Wei EQ, Bringmann A, Wolburg H, Wilhelmsson U, Pekny M, Wiedemann P, Reichenbach A, Kas JA. Reactive glial cells: increased stiffness correlates with increased intermediate filament expression. FASEB J 25: 624–631, 2011.
140. Lubomski M, Louise Rushworth R, Lee W, Bertram KL, Williams DR. Sex differences in Parkinson’s disease. J Clin Neurosci 21: 1503–1506, 2014.
141. 141. Lundgaard I, Osório MJ, Kress B, Sanggaard S, Nedergaard M. White matter astro-cytes in health and disease. Neuroscience doi:10.1016/j.neuroscience.2013.10.050; Epub ahead of print, 2013.
142. Lundkvist A, Reichenbach A, Betsholtz C, Carmeliet P, Wolburg H, Pekny M. Under stress, the absence of intermediate filaments from Muller cells in the retina has structural and functional consequences. J Cell Sci 117: 3481–3488, 2004.
143. Macauley SL, Pekny M, Sands MS. The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. J Neurosci 31: 15575–15585, 2011.
144. Macauley SL, Wozniak DF, Kielar C, Tan Y, Cooper JD, Sands MS. Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse. Exp Neurol 217: 124–135, 2009.
145. Mangin JM, Li P, Scafidi J, Gallo V. Experience-dependent regulation of NG2 progenitors in the developing barrel cortex. Nat Neurosci 15: 1192–1194, 2012.
146. Maragakis NJ, Rothstein JD. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2: 679–689, 2006.
147. Matyash V, Kettenmann H. Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 63: 2–10, 2010.
148. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 93: 6361–6366, 1996.
149. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890–902, 1980.
150. 149a.Menet V, Prieto M, Privat A, Gimenez y Ribotta M. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin. Proc Natl Acad Sci USA 100: 8999–9004, 2003.
151. Messing A, Daniels CML, Hagemann TL. Strategies for treatment in Alexander Disease. Neurotherapeutics 7: 507–515, 2010.
152. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10: 739–743, 2004.
153. Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer’s disease: review and pathogenic implications. Hum Pathol 26: 816–823, 1995.
154. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovas-cular constrictions. Nature 431: 195–199, 2004.
155. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129: 2761–2772, 2006.
156. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10: 615–622, 2007.
157. Nakazawa T, Takeda M, Lewis GP, Cho KS, Jiao J, Wilhelmsson U, Fisher SK, Pekny M, Chen DF, Miller JW. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest Ophthalmol Vis Sci 48: 2760–2768, 2007.
158. Neary JT, Kang Y, Willoughby KA, Ellis EF. Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 puri-nergic receptors. J Neurosci 23: 2348–2356, 2003.
159. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26: 523–530, 2003.
160. Nilsson M, Pekny M. Enriched environment and astrocytes in central nervous system regeneration. J Rehabil Med 39: 345–352, 2007.
161. Nolte C, Matyash M, Pivneva T, Schipke CG, Ohlemeyer C, Hanisch UK, Kirchhoff F, Kettenmann H. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33: 72–86, 2001.
162. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, Xu Q, Wyatt JD, Pilcher W, Ojemann JG, Ransom BR, Goldman SA, Nedergaard M. Uniquely hominid features of adult human astrocytes. J Neurosci 29: 3276–3287, 2009.
163. Oberheim NA, Tian GF, Han X, Peng W, Takano T, Ransom B, Nedergaard M. Loss of astrocytic domain organization in the epileptic brain. J Neurosci 28: 3264–3276, 2008.
164. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12: 829–834, 2006.
165. Orre M, Kamphuis W, Dooves S, Kooijman L, Chan ET, Kirk CJ, Dimayuga Smith V, Koot S, Mamber C, Jansen AH, Ovaa H, Hol EM. Reactive glia show increased immu-noproteasome activity in Alzheimer’s disease. Brain 136: 1415–1431, 2013.
166. Orre M, Kamphuis W, Osborn LM, Melief J, Kooijman L, Huitinga I, Klooster J, Bossers K, Hol EM. Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol Aging 35: 1–14, 2014.
167. Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, Haydon PG, Coulter DA. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13: 584–591, 2010.
168. Overman JJ, Clarkson AN, Wanner IB, Overman WT, Eckstein I, Maguire JL, Dinov ID, Toga AW, Carmichael ST. A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proc Natl Acad Sci USA 109: E2230–2239, 2012.
169. Pannasch U, Freche D, Dallerac G, Ghezali G, Escartin C, Ezan P, Cohen-Salmon M, Benchenane K, Abudara V, Dufour A, Lubke JH, Deglon N, Knott G, Holcman D, Rouach N. Connexin 30 sets synaptic strength by controlling astroglial synapse inva-sion. Nat Neurosci 17: 549–558, 2014.
170. Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, Hempstead BL, Littman DR, Gan WB. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155: 1596–1609, 2013.
171. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RF Jr, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A. Glial cells in (patho)physiology. J Neurochem 121: 4–27, 2012.
172. Pekna M, Pekny M, Nilsson M. Modulation of neural plasticity as a basis for stroke rehabilitation. Stroke 43: 2819–2828, 2012.
173. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 145: 503–514, 1999.
174. Pekny M, Lane EB. Intermediate filaments and stress. Exp Cell Res 313: 2244–2254, 2007.
175. Pekny M, Leveen P, Pekna M, Eliasson C, Berthold CH, Westermark B, Betsholtz C. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J 14: 1590–1598, 1995.
176. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 50: 427–434, 2005.
177. Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204: 428–437, 2004.
178. Pekny M, Stanness KA, Eliasson C, Betsholtz C, Janigro D. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 22: 390–400, 1998.
179. Pekny M, Wilhelmsson U. GFAP and astrocyte intermediate filaments. In: Neuroactive Proteins and Peptides, edited by Lim R. New York: Springer, 2006, p. 290–307.
180. Pekny M, Wilhelmsson U, Pekna M. The dual role of astrocyte activation and reactive gliosis. Neurosci Lett 565: 30–38, 2014.
181. Pekny T, Faiz M, Wilhelmsson U, Curtis MA, Matej R, Skalli O, Pekny M. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease. APMIS 122: 76–80, 2014.
182. Pellerin L, Bouzier-Sore AK, Aubert A, Serres S, Merle M, Costalat R, Magistretti PJ. Activity-dependent regulation of energy metabolism by astrocytes: An update. Glia 55: 1251–1262, 2007.
183. Penfield W, Humphreys S. Epileptogenic lesions of the brain. A histologic study. Arch Neur Psych 43: 240–261, 1940.
184. Planas AM, Justicia C, Soriano MA, Ferrer I. Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia 23: 120–129, 1998.
185. Potokar M, Kreft M, Li L, Daniel Andersson J, Pangrsic T, Chowdhury HH, Pekny M, Zorec R. Cytoskeleton and vesicle mobility in astrocytes. Traffic 8: 12–20, 2007.
186. Potokar M, Stenovec M, Gabrijel M, Li L, Kreft M, Grilc S, Pekny M, Zorec R. Intermediate filaments attenuate stimulation-dependent mobility of endosomes/lyso-somes in astrocytes. Glia 58: 1208–1219, 2010.
187. Puschmann TB, Zanden C, De Pablo Y, Kirchhoff F, Pekna M, Liu J, Pekny M. Bioactive 3D cell culture system minimizes cellular stress and maintains the in vivo-like mor-phological complexity of astroglial cells. Glia 61: 432–440, 2013.
188. Puschmann TB, Zanden C, Lebkuechner I, Philippot C, de Pablo Y, Liu J, Pekny M. HB-EGF affects astrocyte morphology, proliferation, differentiation, and the expres-sion of intermediate filament proteins. J Neurochem 128: 878–889, 2014.
189. Rabchevsky AG, Weinitz JM, Coulpier M, Fages C, Tinel M, Junier MP. A role for transforming growth factor alpha as an inducer of astrogliosis. J Neurosci 18: 10541– 10552, 1998.
190. 188a.Reichenbach A, Wolburg H. Astrocytes and ependymal glia. In: Neuroglia, edited by Kettenmann H and Ransom B. Oxford, UK: Oxford Univ. Press, 2013, p. 33–49.
191. Rakic P. Specification of cerebral cortical areas. Science 241: 170–176, 1988.
192. Ransohoff RM, Perry VH. Microglial physiology: Unique stimuli, specialized respons-es. Annu Rev Immunol27: 119–145, 2009.
193. Renault-Mihara F, Okada S, Shibata S, Nakamura M, Toyama Y, Okano H. Spinal cord injury: emerging beneficial role of reactive astrocytes’ migration. Int J Biochem Cell Biol 40: 1649–1653, 2008.
194. Robel S, Bardehle S, Lepier A, Brakebusch C, Gotz M. Genetic deletion of cdc42 reveals a crucial role for astrocyte recruitment to the injury site in vitro and in vivo. J Neurosci 31: 12471–12482, 2011.
195. Robel S, Berninger B, Gotz M. The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci 12: 88–104, 2011.
196. Robel S, Mori T, Zoubaa S, Schlegel J, Sirko S, Faissner A, Goebbels S, Dimou L, Gotz M. Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. Glia 57: 1630–1647, 2009.
197. Roemgens A, Singh S, Beyer C, Arnold S. Inducers of chemical hypoxia act in a gender-and brain region-specific manner on primary astrocyte viability and cytochrome c oxidase. Neurotoxicity Res 20: 1–14, 2011.
198. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10: 235–241, 2009.
199. Rose CF, Verkhratsky A, Parpura V. Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans 41: 1518–1524, 2013.
200. Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 10: 1377–1386, 2007.
201. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Hoberg MD, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB. beta-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expres-sion. Nature 433: 73–77, 2005.
202. Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322: 1551–1555, 2008.
203. Ruscher K, Kuric E, Wieloch T. Levodopa treatment improves functional recovery after experimental stroke. Stroke 43: 507–513, 2012.
204. Santos-Galindo M, Acaz-Fonseca E, Bellini MJ, Garcia-Segura LM. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differences 2: 7, 2011.
205. Saura J. Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation 4: 26, 2007.
206. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74: 691–705, 2012.
207. Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 358: 787–790, 2001.
208. Schousboe A. Studies of brain metabolism: a historical perspective. Adv Neurol 4: 909–920, 2012.
209. Schummers J, Yu HB, Sur M. Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex. Science 320: 1638–1643, 2008.
210. Schwarz JM, Bilbo SD. Sex, glia, and development: interactions in health and disease. Horm Behav 62: 243–253, 2012.
211. Seifert G, Carmignoto G, Steinhauser C. Astrocyte dysfunction in epilepsy. Brain Res Rev 63: 212–221, 2010.
212. Seifert G, Schilling K, Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 7: 194–206, 2006.
213. Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG. Glial remodeling and neural plasticity in human retinal detachment with proliferative vit-reoretinopathy. Invest Ophthalmol Vis Sci 46: 329–342, 2005.
214. Sharma K, Selzer ME, Li S. Scar-mediated inhibition and CSPG receptors in the CNS. Exp Neurol 237: 370–378, 2012.
215. Shen LH, Li Y, Gao Q, Savant-Bhonsale S, Chopp M. Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain. Glia 56: 1747–1754, 2008.
216. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146–156, 2004.
217. Simard M, Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129: 877–896, 2004.
218. Sims NR, Nilsson M, Muyderman H. Mitochondrial glutathione: a modulator of brain cell death. J Bioenerg Biomembr 36: 329–333, 2004.
219. Sirko S, Behrendt G, Johansson PA, Tripathi P, Costa M, Bek S, Heinrich C, Tiedt S, Colak D, Dichgans M, Fischer IR, Plesnila N, Staufenbiel M, Haass C, Snapyan M, Saghatelyan A, Tsai LH, Fischer A, Grobe K, Dimou L, Gotz M. Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. Cell Stem Cell 12: 426–439, 2013.
220. Smith GM, Strunz C. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52: 209–218, 2005.
221. 219. Smith KM, Dahodwala N. Sex differences in Parkinson’s disease and other movement disorders. Exp Neurol doi: 10.1016/j.expneurol.2014.03.010; Epub ahead of print, 2014.
222. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638–647, 2009.
223. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 11: 400–407, 2005.
224. Sofroniew MV, Bush TG, Blumauer N, Lawrence K, Mucke L, Johnson MH. Geneti-cally-targeted and conditionally-regulated ablation of astroglial cells in the central, enteric and peripheral nervous systems in adult transgenic mice. Brain Res 835: 91–95, 1999.
225. Sofroniew MV, Vinters HV. Astrocytes: Biology and pathology. Acta Neuropathol 119: 7–35, 2010.
226. Sonnenfeld MJ, Jacobs JR. Macrophages and glia participate in the removal of apoptotic neurons from the Drosophila embryonic nervous system. J Comp Neurol 359: 644– 652, 1995.
227. Sriram K, Benkovic SA, Hebert MA, Miller DB, O’Callaghan JP. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? J Biol Chem 279: 19936–19947, 2004.
228. 226. Stahlberg A, Andersson D, Aurelius J, Faiz M, Pekna M, Kubista M, Pekny M. Defining cell populations with single-cell gene expression profiling: correlations and identifica-tion of astrocyte subpopulations. Nucleic Acids Res 39: e24, 2011.
229. Stephan AH, Madison DV, Mateos JM, Fraser DA, Lovelett EA, Coutellier L, Kim L, Tsai HH, Huang EJ, Rowitch DH, Berns DS, Tenner AJ, Shamloo M, Barres BA. A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci 33: 13460–13474, 2013.
230. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA. The classical complement cascade mediates CNS synapse elim-ination. Cell 131: 1164–1178, 2007.
231. Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 29: 2381–2393, 1998.
232. Sullivan HG, Martinez J, Becker DP, Miller JD, Griffith R, Wist AO. Fluid-percussion model of mechanical brain injury in the cat. J Neurosurg 45: 521–534, 1976.
233. Sun W, Dietrich D. Synaptic integration by NG2 cells. Front Cell Neurosci 7: 255, 2013.
234. Takano T, Oberheim N, Cotrina ML, Nedergaard M. Astrocytes and ischemic injury. Stroke 40: S8–12, 2009.
235. Theis M, Sohl G, Eiberger J, Willecke K. Emerging complexities in identity and function of glial connexins. Trends Neurosci 28: 188–195, 2005.
236. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke HR, Kang J, Nedergaard M. An astrocytic basis of epilepsy. Nat Med 11: 973– 981, 2005.
237. Titler AM, Posimo JM, Leak RK. Astrocyte plasticity revealed by adaptations to severe proteotoxic stress. Cell Tissue Res 352: 427–443, 2013.
238. Tsai HH, Li H, Fuentealba LC, Molofsky AV, Taveira-Marques R, Zhuang H, Tenney A, Murnen AT, Fancy SP, Merkle F, Kessaris N, Alvarez-Buylla A, Richardson WD, Rowitch DH. Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science 337: 358–362, 2012.
239. Ullian EM, Christopherson KS, Barres BA. Role for glia in synaptogenesis. Glia 47: 209–216, 2004.
240. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. Control of synapse number by glia. Science 291: 657–661, 2001.
241. Van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, Tumas D, Gerlai R, Williams SP, van Lookeren Campagne M, Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104: 1613–1620, 1999.
242. Vangeison G, Rempe DA. The Janus-faced effects of hypoxia on astrocyte function. Neuroscientist 15: 579–588, 2009.
243. 241. Vardjan N, Gabrijel M, Potokar M, Kreft M, Jeras M, de Pablo Y, Faiz M, Pekny M, Zorec R. IFN-gamma-induced increase in the mobility of MHC class II compart-ments in astrocytes depends on intermediate filaments. J Neuroinflammation 9: 144, 2012.
244. Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. Nrf2 activation in astro-cytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28: 13574–13581, 2008.
245. Verardo MR, Lewis GP, Takeda M, Linberg KA, Byun J, Luna G, Wilhelmsson U, Pekny M, Chen DF, Fisher SK. Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin. Invest Ophthalmol Vis Sci 49: 3659–3665, 2008.
246. 244. Verkhratsky A, Butt A. Astroglia. In: Glial Physiology and Pathophysiology. Hoboken, NJ: Wiley, 2013, p. 105–231.
247. 245. Verkhratsky A, Butt A. General pathophysiology of neuroglia. In: Glial Physiology and Pathophysiology. Hoboken, NJ: Wiley, 2013, p. 431–450.
248. Verkhratsky A, Butt A. Neuroglia in neurological diseases. In: Glial Physiology and Pathophysiology. Hoboken, NJ: Wiley, 2013, p. 453–504.
249. Verkhratsky A, Butt A. Periphreal glial cells. In: Glial Physiology and Pathophysiology. Hoboken, NJ: Wiley, 2013, p. 381–433.
250. Verkhratsky A, Rodriguez JJ, Parpura V. Neuroglia in ageing and disease. Cell Tissue Res 357: 493–503, 2014.
251. Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodriguez JJ, Nedergaard M. Neurological diseases as primary gliopathies: a reassessment of neu-rocentrism. ASN Neuro 4: 2012.
252. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376: 584–587, 1995.
253. Voskuhl RR, Gold SM. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 8: 255–263, 2012.
254. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29: 11511–11522, 2009.
255. Wang L, Sharma K, Grisotti G, Roos RP. The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis. Neurobiol Dis 35: 234–240, 2009.
256. Wang X, Hasan O, Arzeno A, Benowitz LI, Cafferty WB, Strittmatter SM. Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways. Exp Neurol 237: 55–69, 2012.
257. Wang Y, Lin SZ, Chiou AL, Williams LR, Hoffer BJ. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci 17: 4341–4348, 1997.
258. Wanner IB, Anderson MA, Song B, Levine J, Fernandez A, Gray-Thompson Z, Ao Y, Sofroniew MV. Glial scar borders are formed by newly proliferated, elongated astro-cytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci 33: 12870–12886, 2013.
259. Wei G, Wu G, Cao X. Dynamic expression of glial cell line-derived neurotrophic factor after cerebral ischemia. Neuroreport 11: 1177–1183, 2000.
260. Wetherington J, Serrano G, Dingledine R. Astrocytes in the epileptic brain. Neuron 58: 168–178, 2008.
261. Widestrand A, Faijerson J, Wilhelmsson U, Smith PL, Li L, Sihlbom C, Eriksson PS, Pekny M. Increased neurogenesis and astrogenesis from neural progenitor cells grafted in the hippocampus of GFAP-/-Vim-/- mice. Stem Cells 25: 2619–2627, 2007.
262. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, Ellisman MH, Pekny M. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci USA 103: 17513– 17518, 2006.
263. Wilhelmsson U, Faiz M, de Pablo Y, Sjoqvist M, Andersson D, Widestrand A, Potokar M, Stenovec M, Smith PL, Shinjyo N, Pekny T, Zorec R, Stahlberg A, Pekna M, Sahlgren C, Pekny M. Astrocytes negatively regulate neurogenesis through the Jag-ged1-mediated Notch pathway. Stem Cells 30: 2320–2329, 2012.
264. Wilhelmsson U, Li L, Pekna M, Berthold CH, Blom S, Eliasson C, Renner O, Bushong E, Ellisman M, Morgan TE, Pekny M. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 24: 5016–5021, 2004.
265. Winter CG, Saotome Y, Levison SW, Hirsh D. A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central-nervous-system injury. Proc Natl Acad Sci USA 92: 5865–5869, 1995.
266. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12: 1005–1015, 2006.
267. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Huse-mann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9: 453–457, 2003.
268. Xia XG, Hofmann HD, Deller T, Kirsch M. Induction of STAT3 signaling in activated astrocytes and sprouting septal neurons following entorhinal cortex lesion in adult rats. Mol Cell Neurosci 21: 379–392, 2002.
269. Yamaguchi H, Sugihara S, Ogawa A, Saido TC, Ihara Y. Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol 95: 217–222, 1998.
270. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251–253, 2008.
271. Yick LW, Wu WT, So KF, Yip HK, Shum DKY. Chondroitinase ABC promotes axonal regeneration of Clarke’s neurons after spinal cord injury. Neuroreport 11: 1063–1067, 2000.
272. Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 26: 10939–10948, 2006.
273. Zamanian JL, Xu LJ, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA. Genomic analysis of reactive astrogliosis. J Neurosci 32: 6391–6410, 2012.
274. Zhang J, Malik A, Choi HB, Ko RW, Dissing-Olesen L, MacVicar BA. Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 82: 195–207, 2014.
275. Zhang Y, Barres BA. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr Opin Neurobiol 20: 588–594, 2010.
276. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8: 491–500, 2009.
277. Zhao Y, Rempe DA. Targeting astrocytes for stroke therapy. Neurotherapeutics 7: 439–451, 2010.
278. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T, Carmignoto G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6: 43–50, 2003.